UK launches first national vitiligo registry to monitor treatment safety

NCT ID NCT06218082

Not yet recruiting Knowledge-focused Sponsor: The Royal Wolverhampton Hospitals NHS Trust Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study creates a UK-wide registry for people with vitiligo, a skin condition causing white patches. It will track the safety and effectiveness of current treatments in up to 30 patients. The goal is to improve long-term care by collecting real-world data from dermatologists.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could provide valuable real-world data on vitiligo treatments, helping doctors choose safer and more effective therapies.
What could go wrong: This is a small observational registry, not a treatment trial. It will not directly test new therapies, and results may take years to influence practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DERMATOLOGIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

skin disorder vitiligo

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DERMATOLOGIC DISEASE VITILIGO

Contacts and locations

Locations

The Royal Wolverhampton NHS Trust

Wolverhampton, WV10 0QP, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.